SDZ 224-015 is a potent, orally bioavailable inhibitor of the IL-1beta converting enzyme (caspase-1). It demonstrates anti-inflammatory and anti-COVID-19 activity in research, validated by its efficacy in reducing carrageenan-induced paw edema in rat models and its use in cytokine storm-related in vitro studies.